Two‐year biochemical, virological, and histological follow‐up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa‐2b treatment
Olle Reichard, Hans Glaumann, Aril Frydén, Gunnar Norkrans, Robert Schvarcz, Anders Sönnerborg, Zhi‐Bing Yun, Ola Weiland – 1 April 1995 – Fourteen patients with chronic hepatitis C who had a sustained response to a 60‐week interferon alfa‐2b treatment course were followed, biochemically and virologically, 2 years after treatment cessation. Biopsies were repeated in 12 of 14 for histological and virological evaluation at 2‐year follow‐up.